Yanai, H.; Adachi, H.; Hakoshima, M.; Katsuyama, H.
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int. J. Mol. Sci. 2021, 22, 9221.
https://doi.org/10.3390/ijms22179221
AMA Style
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. International Journal of Molecular Sciences. 2021; 22(17):9221.
https://doi.org/10.3390/ijms22179221
Chicago/Turabian Style
Yanai, Hidekatsu, Hiroki Adachi, Mariko Hakoshima, and Hisayuki Katsuyama.
2021. "Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease" International Journal of Molecular Sciences 22, no. 17: 9221.
https://doi.org/10.3390/ijms22179221
APA Style
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H.
(2021). Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. International Journal of Molecular Sciences, 22(17), 9221.
https://doi.org/10.3390/ijms22179221